Ascentage Pharma Group International (FRA:36X)
Germany flag Germany · Delayed Price · Currency is EUR
6.95
-0.05 (-0.71%)
Last updated: Dec 1, 2025, 8:59 AM CET

FRA:36X Revenue

Ascentage Pharma Group International had revenue of 116.85M CNY in the half year ending June 30, 2025, a decrease of -71.63%. This brings the company's revenue in the last twelve months to 390.60M, down -56.75% year-over-year. In the year 2024, Ascentage Pharma Group International had annual revenue of 980.65M with 341.77% growth.

Revenue (ttm)
390.60M CNY
Revenue Growth
-56.75%
P/S Ratio
55.77
Revenue / Employee
688.89K CNY
Employees
567
Market Cap
2.59B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024980.65M758.67M341.77%
Dec 31, 2023221.98M12.27M5.85%
Dec 31, 2022209.71M181.80M651.38%
Dec 31, 202127.91M15.46M124.18%
Dec 31, 202012.45M-2.06M-14.21%
Dec 31, 201914.51M7.71M113.21%
Dec 31, 20186.81M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition